Search research articles
Contact Us
Filters
Showing results (621-630 of 640) with videos related to
Page
of 64
Sort By:
Leukemia
|
September 19, 2017
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse
P Boddu, J Jorgensen, H Kantarjian, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 16, 1998
In vivo accuracy of two radiographic systems in the detection of Björk-Shiley convexo-concave heart valve outlet strut single leg separations
K D Hopper, I C Gilchrist, J R Landis, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 9, 2010
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode
Marvin J Meyers, Matthew Pelc, Satwik Kamtekar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 19, 2010
A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation
Robert J Mourey, Barry L Burnette, Sarah J Brustkern, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2017
Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)
P Jain, E Aoki, M Keating, et al.
Physical Review Letters
|
February 9, 2005
Disorder-induced microscopic magnetic memory
M S Pierce, C R Buechler, L B Sorensen, et al.
CA: a Cancer Journal for Clinicians
|
October 23, 2003
Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices
Jean K Brown, Tim Byers, Colleen Doyle, et al.
Leukemia
|
June 15, 2013
Toll-like receptor alterations in myelodysplastic syndrome
Y Wei, S Dimicoli, C Bueso-Ramos, et al.
Leukemia
|
November 1, 2016
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials
G Montalban-Bravo, X Huang, K Naqvi, et al.
Bioorganic & Medicinal Chemistry
|
April 8, 2020
Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1
Andrew Fensome, Catherine M Ambler, Eric Arnold, et al.
Page
of 64
Search research articles
Search
Showing results (621-630 of 640) with videos related to
Sort By:
Page
of 64
Leukemia
|
September 19, 2017
Achievement of a negative minimal residual disease state after hypomethylating agent therapy in older patients with AML reduces the risk of relapse
P Boddu, J Jorgensen, H Kantarjian, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
April 16, 1998
In vivo accuracy of two radiographic systems in the detection of Björk-Shiley convexo-concave heart valve outlet strut single leg separations
K D Hopper, I C Gilchrist, J R Landis, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 9, 2010
Structure-based drug design enables conversion of a DFG-in binding CSF-1R kinase inhibitor to a DFG-out binding mode
Marvin J Meyers, Matthew Pelc, Satwik Kamtekar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 19, 2010
A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation
Robert J Mourey, Barry L Burnette, Sarah J Brustkern, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 6, 2017
Characteristics, outcomes, prognostic factors and treatment of patients with T-cell prolymphocytic leukemia (T-PLL)
P Jain, E Aoki, M Keating, et al.
Physical Review Letters
|
February 9, 2005
Disorder-induced microscopic magnetic memory
M S Pierce, C R Buechler, L B Sorensen, et al.
CA: a Cancer Journal for Clinicians
|
October 23, 2003
Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices
Jean K Brown, Tim Byers, Colleen Doyle, et al.
Leukemia
|
June 15, 2013
Toll-like receptor alterations in myelodysplastic syndrome
Y Wei, S Dimicoli, C Bueso-Ramos, et al.
Leukemia
|
November 1, 2016
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials
G Montalban-Bravo, X Huang, K Naqvi, et al.
Bioorganic & Medicinal Chemistry
|
April 8, 2020
Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl)pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1
Andrew Fensome, Catherine M Ambler, Eric Arnold, et al.
Page
of 64